1 State Key Laboratory of Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 510120 Guangzhou, Guangdong, China
2 Providence VA Medical Center, Providence, RI 02908, USA
3 Division of Biology and Medicine, Brown University, Providence, RI 02912, USA
4 Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI 02912, USA
5 Center for Computational Biology of Human Disease and Center for Computation and Visualization, Brown University, Providence, RI 02912, USA
6 Departments of Pediatrics, Brown University, Providence, RI 02912, USA
7 Departments of Medicine, Brown University, Providence, RI 02912, USA
†These authors contributed equally.
Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants. Neonatal hyperoxia induces a BPD-like phenotype and lung cell senescence in rodents. In our 3-day hyperoxia model, senescent cells were predominantly lung macrophages, with their abundance peaking at postnatal day 7 (pnd7). However, the molecular and functional characteristics of these senescent macrophages remain undefined.
We reanalyzed a scRNA-seq dataset (GSE207866) generated from senescent lung cells isolated at pnd7 (SD7) following neonatal hyperoxia. Hierarchical clustering combined with manual annotation was used to compare transcriptional profiles with age-matched air-exposed controls (AirD7) and hyperoxia-exposed mice without senescent-cell enrichment (O2D7). Key molecular findings were validated by immunofluorescence. In vivo, neonatal mice received daily injections of the pyruvate dehydrogenase kinase inhibitor, dichloroacetate (DCA) from pnd4 to pnd6, and a senolytic cocktail consisting of quercetin and dasatinib from pnd4 to pnd14, following 3 days of hyperoxia exposure.
Macrophages accounted for 65.90% of senescent cells in the SD7 group. Seven macrophage clusters were identified, enriched in M1-like and alveolar macrophage phenotypes. Two major clusters (clusters 0 and 1), together representing nearly half of all senescent macrophages, exhibited strong expression of genes associated with innate immunity, inflammation, and DNA damage responses. These clusters also showed a shift toward glycolysis, the pentose phosphate pathway, and glutamine metabolism, with reduced reliance on β-oxidation. Administration of DCA activated pyruvate dehydrogenase and attenuated hyperoxia-induced macrophage senescence and lung injury. Pathway enrichment analyses revealed enhanced metal-handling pathways, immune and stress signaling (including p38 mitogen-activated kinase, ataxia-telangiectasia mutated, and mechanistic target of rapamycin), apoptosis, and RNA regulatory processes. Conversely, genes involved in reactive oxygen species detoxification, DNA repair, phagocytosis, cytoskeletal organization, and cell adhesion were downregulated. Notably, reducing senescent cells by a senolytic cocktail during the alveolar stage mitigated hyperoxia-induced persistent lung injury.
Neonatal hyperoxia drives the emergence of a heterogeneous population of senescent macrophages characterized by metabolic reprogramming and dysregulated signaling pathways, which contribute to the development and persistence of lung injury.
Keywords
- bronchopulmonary dysplasia
- single-cell gene expression analysis
- cellular senescence
- macrophages
- metabolism
Bronchopulmonary dysplasia (BPD) is a chronic lung disease of prematurity that
arises from a combination of factors, including exposure to supplemental oxygen,
mechanical ventilation, and other perinatal insults. In the US, approximately
10,000–15,000 premature infants develop BPD each year, with an estimated
first-year medical cost approaching
Emerging evidence indicates that cellular senescence may contribute to the
pathogenesis of BPD. Airway smooth muscle cells from oxygen-exposed infants
exhibit increased markers of senescence compared with those from infants who died
shortly after birth without oxygen exposure [5]. Similarly, premature infants
requiring mechanical ventilation show a notable reduction in nuclear lamin B1 in
distal alveoli, consistent with heightened senescence [6]. Additional studies
have reported increased senescence-associated biomarkers, including lipofuscin
accumulation, phosphorylated p53, and
To address this gap, we reanalyzed a single-cell RNA sequencing dataset (GSE207866) of senescent lung cells isolated from hyperoxia-exposed neonatal mice at pnd7 (SD7). The dataset is limited to senescent cell populations and thus does not include a corresponding hyperoxia-exposed, non-senescent cell-enriched group for comparison. Using hierarchical clustering and comparative transcriptomic analyses [8], we characterized the gene expression profiles and pathway enrichment signatures of senescent macrophages and contrasted them with age-matched air controls (AirD7) and non-senescent cells from hyperoxia-exposed mice (O2D7). Portions of these analyses have been deposited in bioRxiv [9]. Mice were injected a pyruvate dehydrogenase (Pdh) kinase (PDK) inhibitor to determine whether activating Pdh decreases hyperoxia-induced macrophage senescence, alveolar and vascular simplification. Finally, we evaluated whether senolytic treatment during the alveolar stages inhibits neonatal hyperoxia-induced persistent lung injury.
Newborn C57BL/6J mice (
For a senolytic cocktail treatment, mice received quercetin and dasatinib (2.5 and 5 mg/kg, i.p.) from pnd4 to pnd14 following neonatal exposure to room air or hyperoxia. These doses were selected based on prior reports demonstrating effective senescent-cell clearance without toxicity [6]. In a separate experiment, a PDK kinase inhibitor sodium dichloroacetate (DCA, 15 and 30 mg/kg, i.p.) was injected daily between pnd4 and pnd6. Animals were anesthetized with ketamine (75 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.), prepared from stock solutions of ketamine (10%, w/v) and xylazine (2%, w/v) and diluted in sterile saline to achieve the appropriate injection volume. Mice were then cervical dislocated following confirmation of deep anesthesia and complete loss of reflexes, with subsequent removal of vital organs.
Lung morphometric analyses were performed on hematoxylin and eosin (H&E)-stained mouse lung sections. Non-lavaged lungs were gently inflated with 1% low-melting point agarose at a constant pressure of 25 cm H2O and subsequently fixed in 4% neutral-buffered paraformaldehyde. After fixation, lung tissues were paraffin-embedded and sectioned at a thickness of 4 µm using a rotary microtome (Leica Biosystems, Deer Park, IL, USA). Radial alveolar count (RAC) was determined by drawing a perpendicular line from the center of a respiratory bronchiole to the distal acinus, defined by the pleural surface or the nearest connective tissue septum, and counting the number of alveolar septa intersected by this line. At least three measurements were obtained per animal to ensure reliable quantification.
Paraffin-embedded lung sections underwent deparaffinization and heat-induced
antigen retrieval prior to immunofluorescence staining. Samples were incubated
overnight at 4 ℃ with primary antibodies against Pdh E1 subunit
Pdh activity was assessed in protein lysates prepared from snap-frozen lung
tissue using a commercially available kit (ab287837; Abcam). Approximately 50 mg
of frozen lung tissue was homogenized in 300 µL of ice-cold assay buffer
and incubated on ice for 10 min. The homogenate was then centrifuged at 10,000
Previously published single-cell RNA-seq data (GEO: GSE207866) from senescent lung cells isolated at pnd7 (SD7) were used for analysis [6]. Single-cell datasets from age-matched air-exposed (AirD7) and hyperoxia-exposed (O2D7) mice served as reference controls.
Data processing was carried out in Seurat v4.1.1 (Satija Lab, New York, NY, USA)
[10]. CellRanger count matrices (10
Normalization and scaling were performed with SCTransform using default parameters. Integration of Seurat objects employed canonical correlation analysis with SelectIntegrationFeatures(), PrepSCTIntegration(), FindIntegrationAnchors(), and IntegrateData(). Principal component analysis (first 50 PCs) was used to build a K-nearest neighbor graph (K = 20), followed by Louvain clustering using FindClusters(). Cluster resolution was guided by clustree v0.5.1 [11]. UMAP visualization was generated using the first 50 CCA embeddings. Cell types were assigned based on established marker genes (Table 1).
| Cell type | Canonical markers | Level | Note |
| Epithelial | Epcam | 1 | |
| Endothelial | Pecam1 | 1 | |
| Mesenchymal | Col1a1, Col1a2, Acta2, Myl9 | 1 | |
| Immune | Ptprc (Cd45) | 1 | Selected |
| Neutrophil | S100a9, Ifitm2, Fcgr4 | 2 | |
| Mast cell/Basophil | Ms4a2, Cpa3 | 2 | |
| T cells | Cd4, Cd3e, Cd8a | 2 | |
| NK cells | Klrd1, Nkg7 | 2 | |
| B cells | Cd79a, Cd19 | 2 | |
| Dendritic cell | Hba-a1, Hba-a2, Clec9a, Lamp3, Zbtb46, Flt3, Sirpa | 2 | Selected |
| Monocyte | Cd68, Cd14, S100a8, Fcgr3 (Cd16) | 2 | Selected |
| Macrophage | Cd68, Itgax (Cd11c), Adgre1 (F4/80), Mertk, Marco, Msr1, Mrc1 (Cd206) | 2 | Selected |
| General monocyte | Ly6c2, Vcan | 3 | |
| Classical monocyte | Cd14, S100a8 | 3 | |
| Interstitial monocyte/non-classical monocyte | Fcgr3 (Cd16), Plac8, Cx3cr1, Spn, Itgal | 3 | |
| General dendritic cell | Zbtb46, Flt3 | 3 | |
| Dendritic cell 1 | Clec9a, Itgae (Cd103), Irf8 | 3 | |
| CD301b- dendritic cell 2 | S100a4, S100a6, Irf4 | 3 | |
| CD301b+ dendritic cell 2 | Mgl2, Cd209a, Siglecg | 3 | |
| Inflammatory dendritic cell 2 | Phf11d, Ifit3, Ifi205 | 3 | |
| Migratory dendritic cell | Ccl17, Ccl22 | 3 | |
| General macrophage | Cd68, Itgax (Cd11c), Adgre1 (F4/80), Mertk, Marco, Msr1, Mrc1 (Cd206) | 3 | Selected |
| Alveolar macrophage | Gpd1, Siglec1, Siglecf, Marco, Car4, Fabp1, Krt19 | 3, 4 | Selected |
| Interstitial macrophage | Apoe, Ccl12, C1qc, C1qa, Folr2, Lyve1, Adgre1 (F4/80) | 3, 4 | Selected |
| Non-classical interstitial macrophage | Ctsz, Ctsd, Esd, Mmp12 | 3, 4 | Selected |
| Recruited macrophage/Monocyte-derived macrophages | Fn1, Il1b, Ccr2, Vcan | 3, 4 | Selected |
| Proliferating macrophage | Cenpf, Mki67, Stmn1, Top2a, Cdk1 | 3, 4 | Selected |
| M1 macrophage | Cd68, Cd80, Cd86, Cd38, Fcgr3, Fpr2, Stat1, Il1a, Cxcl2, Itgax (Cd11c) | 3, 4 | Selected |
| M1/M2 macrophage | C1qa, C1qc | 3, 4 | Selected |
| M2 macrophage | Cd163, Arg1, Arg2, Tgfb1, Fn1, Lyve1, Itgam (Cd11b), Tlr1 | 3, 4 | Selected |
The same workflow was repeated iteratively to derive subclusters within each major lineage. Immune cells were isolated from the global dataset, and macrophages were distinguished from monocytes and dendritic cells. This approach yielded seven macrophage subsets (518 cells) for downstream analyses. Marker genes for each macrophage subset were identified using the cosg() function [12]. Figures were generated with SCpubr v2.0.0, scplotter v0.1.1, and fmsb v0.7.6 in R v4.4.1 using RStudio v2023.12.0 (RStudio/Posit, Boston, MA, USA).
Gene sets representing GO biological processes, KEGG pathways, Reactome, PID,
BioCarta, and WikiPathways were obtained from the Molecular Signatures Database
(v7) (Broad Institute, Cambridge, MA, USA) [13]. Pathway comparisons were carried
out using compare_pathways() in SCPA v1.6.2 (Broad Institute, Cambridge, MA,
USA) (parameters: min_genes = 15; max_genes = 500) [14]. Macrophage populations
from AirD7, O2D7, and SD7 were analyzed. Visualization and post-processing were
performed using Seurat v4.4.0 [10] and ggplot2 v3.5.1 (RStudio/Posit Software,
Boston, MA, USA). Pathways with
Single-cell trajectory analysis of seven macrophage clusters was performed using
Monocle2 (v2.32.0) (Trapnell Lab, University of Washington, Seattle, WA, USA)
[15]. Prior to cell ordering, the differentialGeneTest function was applied to
identify differentially expressed genes (DEGs) across clusters, and genes with a
q value
AUCell (Version 1.26.0) (Bioconductor, Buffalo, NY, USA) [16] was employed to
assign metabolic pathways activity scores in the single-cell RNA data. Initially,
a ranking of selected pathways genes was built based on the single-cell
expression matrix using the AUCell_buildRankings() function with default
parameters. Subsequently, the area under the curve (AUC) was calculated using the
top 5% of genes in the ranking using the AUCell_calcAUC() function. Cells
expressing a higher proportion of genes within the gene set received higher AUC
values. The AUC score for each cell was mapped onto violin and box plots for
visualization using the ggplot2 v3.5.1. Finally, the Wilcoxon rank-sum test for
multiple comparisons was performed using the stat_compare_means function from
the ggpubr v0.6.0 (RStudio/Posit Software, Boston, MA, USA). A p-value
Data are presented as mean
Using canonical marker genes (Table 1), we first assigned all single cells in the AirD7, O2D7, and SD7 datasets to epithelial, endothelial, immune, or mesenchymal lineages (Table 1, level 1). Immune populations corresponded to clusters 5, 6, 12, 14, 16, 18, 19, 21, 25, 26, 30, 32, and 33 (Fig. 1A). Among the 493 SD7 cells, 73.63% were immune cells, with smaller fractions of epithelial (8.11%), endothelial (9.74%), and mesenchymal (8.52%) cells (Table 2). Thus, immune populations constituted the largest senescent pool.
Fig. 1.
Immune cell and coarse macrophage distributions at postnatal day 7 (pnd7). Reanalysis of public lung scRNA-seq datasets (GSE207866) was performed using lung single-cell suspensions without C12FDG sorting from air-exposed (AirD7) and hyperoxia-exposed (O2D7) mice, as well as C12FDG-sorted cells from the hyperoxia group (SD7). (A,B) Dot plots display cell type identification, including Ptprc (CD45)-positive immune clusters (A) and coarse macrophage/monocyte subpopulations (B). Dot size indicates the proportion of cells expressing the gene within a cluster, and color intensity represents expression levels.
| Cluster | Total (n) | AirD7 (n) | O2D7 (n) | SD7 (n) |
| All | 4047 | 2308 | 1246 | 493 |
| Immune | 1220 (30.15%) | 532 (23.05%) | 325 (26.08%) | 363 (73.63%) |
| Epithelial | 903 (22.31%) | 562 (24.35%) | 301 (24.16%) | 40 (8.11%) |
| Endothelial | 487 (12.03%) | 212 (9.19%) | 227 (18.22%) | 48 (9.74%) |
| Mesenchymal | 1437 (35.51%) | 1002 (43.41%) | 393 (31.54%) | 42 (8.52%) |
To further resolve these immune cells, all immune clusters were combined and reclassified using lineage-specific markers (Table 1, level 2). Eight immune cell types, such as B cells, NK cells, T cells, mast cells/basophils, neutrophils, monocytes, dendritic cells, and macrophages, were identified. Monocytes, dendritic cells, and macrophages accounted for 63.3% of immune cells overall (within clusters 0, 1, 3, 4, 6, 7, 11, and 15), and 97.5% of immune cells in the SD7 group (Fig. 1B; Table 3). Clusters 3 and 6 expressed overlapping signatures of macrophages with monocytes or dendritic cells. These clusters were combined with other myeloid clusters and refined using additional markers (Table 1, level 3).
| Cluster | Total (n) | AirD7 (n) | O2D7 (n) | SD7 (n) |
| All | 1220 | 532 | 325 | 363 |
| Macrophage/Monocyte/DC | 772 (63.28%) | 246 (46.24%) | 172 (52.92%) | 354 (97.52%) |
| Neutrophil | 29 (2.38%) | 14 (2.63%) | 14 (4.31%) | 1 (0.28%) |
| Mast/Basophil | 15 (1.23%) | 7 (1.32%) | 6 (1.85%) | 2 (0.55%) |
| T cells | 159 (13.03%) | 110 (20.68%) | 47 (14.46%) | 2 (0.55%) |
| NK cells | 52 (4.26%) | 34 (6.39%) | 18 (5.54%) | 0 (0%) |
| B cells | 193 (15.82%) | 121 (22.74%) | 68 (20.92%) | 4 (1.10%) |
This analysis produced eleven initial subclusters (Fig. 2A). Clusters 2, 3, 5, 6, 7, 8, 9, and 10 showed clear macrophage identity, while clusters 1 and 4 contained mixed dendritic cell and macrophage markers. Subclustering of clusters 1 and 4 allowed extraction of macrophages, which were integrated with the eight pre-defined macrophage clusters (Fig. 2B). This produced seven final macrophage subsets (clusters 0–6), totaling 518 macrophages: 116 in AirD7, 77 in O2D7, and 325 in SD7 (Tables 4,5). In SD7, macrophages represented 65.90% of all senescent cells, confirming that macrophages are the dominant senescent population after neonatal hyperoxia. We then used these seven clusters of macrophages for further analyses.
Fig. 2.
Identification of macrophage populations. (A,B) Dot plots depict cell type identification of macrophages from the total coarse macrophage population (A) and the selection of macrophages from mixed subpopulations in clusters 1 and 4 (B). Dot size reflects the percentage of cells expressing each gene, and color intensity represents expression level.
| Group | Total | Macrophages |
| AirD7 (n) | 2308 | 116 (5.03%) |
| O2D7 (n) | 1246 | 77 (6.18%) |
| SD7 (n) | 493 | 325 (65.90%) |
| Cluster | Total (n) | AirD7 (n) | O2D7 (n) | SD7 (n) |
| All | 518 | 116 | 77 | 325 |
| 0 | 125 | 25 | 18 | 82 |
| 1 | 112 | 25 | 9 | 78 |
| 2 | 83 | 21 | 21 | 41 |
| 3 | 61 | 12 | 5 | 44 |
| 4 | 56 | 12 | 12 | 32 |
| 5 | 44 | 14 | 10 | 20 |
| 6 | 37 | 7 | 2 | 28 |
Neonatal hyperoxia drives inflammatory injury with a shift toward M1 polarization [17], but its effects on senescent macrophages are unclear. Polarization analysis of the 325 SD7 macrophages using canonical markers (Table 1) showed that clusters 0, 1, 5, and 6 displayed M1 signatures; cluster 4 aligned with M2; and clusters 2 and 3 exhibited mixed M1/M2 characteristics (Fig. 3A–C). Although total macrophage numbers were reduced in O2D7 compared with AirD7, the distribution of M1, M2, and mixed phenotypes remained similar across groups (Table 6). M1 cells were the dominant subtype in all conditions. Lamin b1 loss is a senescence-associated biomarker [18]. Immunostaining showed that NOS2 (M1 marker) was enriched in lamin b1 negative macrophages at pnd7, whereas the M2-associated protein Syk was reduced in the hyperoxic group compared to air control (Fig. 3D). These results suggest that senescent macrophages formed after hyperoxia predominantly adopt an M1-like inflammatory state.
Fig. 3.
Classification of M1, M2, and mixed M1/M2 macrophages. (A) Dot
plot shows expression of curated M1, M2, and mixed M1/M2 genes in total
macrophages. The size of the dot represents the percentage of cells within a
cluster expressing the indicated gene, while the intensity of expression is
indicated by the color legend. Colored boxes are used to highlight
marker gene sets that define different macrophage phenotypes and to guide
interpretation of the dot plot. (B) Cluster assignment of M1, M2, and
mixed M1/M2 macrophages. (C) UMAP plot illustrates the spatial distribution of
these macrophages, with cells colored by type; ring plots indicate proportions in
each group. (D) Dual immunofluorescence staining of lamin b1 with NOS2 or Syk at
pnd7 in hyperoxia-exposed lungs. lamin b1–/NOS2+ and lamin
b1–/Syk+ signals were quantified between air and hyperoxia groups.
White arrows indicate representative macrophages showing altered NOS2 or SYK
expression and reduced lamin b1 signal. Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal. Scale bar: 50 µm for the main panel, and 10 µm for the inset. N = 3; *p
| Group | Macrophages (total cells, %) | M1 | Mixed M1 and M2 | M2 |
| AirD7 (n) | 116 (2308, 5.0%) | 71 (61.2%) | 33 (28.4%) | 12 (10.3%) |
| O2D7 (n) | 77 (1246, 6.2%) | 39 (50.6%) | 26 (33.8%) | 12 (15.6%) |
| SD7 (n) | 325 (493, 65.9%) | 208 (64.0%) | 85 (26.2%) | 32 (9.85%) |
Because lung macrophages occupy both alveolar and interstitial compartments, we next assessed whether senescence preferentially affects specific subsets. Among the 325 SD7 macrophages, marker-based classification identified alveolar, interstitial, recruited/monocyte-derived, proliferative, and non-classical interstitial macrophages (Table 1). Clusters 0, 1, and 3 corresponded to alveolar macrophages, while clusters 2, 4, 5, and 6 mapped to interstitial, recruited/monocytes-derived, proliferative, and non-classical interstitial macrophages, respectively (Fig. 4).
Fig. 4.
Functional- and tissue-specific macrophage subsets. (A) Dot plot shows expression of curated genes for functional and tissue-specific macrophage subsets. The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. Colored boxes are used to highlight marker gene sets that define different macrophage phenotypes and to guide interpretation of the dot plot. (B) Cluster allocation of alveolar macrophages (AlvMac), interstitial macrophages (IMac), non-classical interstitial macrophages (ncIMac), recruited/monocyte-derived macrophages (recMac/Mo-Mac), and proliferative macrophages (pMac). (C) UMAP plot illustrates the distribution of these macrophages, with ring plots showing subtype proportions in each group.
In O2D7 mice, alveolar macrophage proportions were decreased and interstitial macrophages increased relative to AirD7 (Table 7). The proportions of recruited/monocyte-derived macrophages, proliferative macrophages, and non-classical interstitial macrophages were largely comparable between the AirD7 and O2D7 groups, with no substantial differences observed. In contrast, senescent macrophages in SD7 were predominantly alveolar (62.8%), with reduced representation of interstitial and proliferative subsets compared with the AirD7 group (Table 7). These results indicate that neonatal hyperoxia reshapes the macrophage landscape and that alveolar macrophages are the most susceptible to senescence.
| Group | Mac | AlvMac | IMac | ncIMac | recMac/Mo-Mac | pMac |
| AirD7 (n) | 116 | 62 (53.4%) | 21 (18.1%) | 7 (6.03%) | 12 (10.3%) | 14 (12.1%) |
| O2D7 (n) | 77 | 32 (41.6%) | 21 (27.3%) | 2 (2.60%) | 12 (15.6%) | 10 (13.0%) |
| SD7 (n) | 325 | 204 (62.8%) | 41 (12.6%) | 28 (8.62%) | 32 (9.85%) | 20 (6.15%) |
AlvMac, alveolar macrophages; IMac, interstitial macrophages; recMac/Mo-Mac, recruited macrophages/monocytes-derived macrophages; pMac, proliferative macrophages; ncIMac, non-classical interstitial macrophages.
To investigate potential transcriptional state transitions among the seven macrophage clusters, we performed Monocle2 pseudotime trajectory analysis using all clusters (Fig. 5A). The inferred trajectory revealed two major branch points, partitioning cells into five distinct transcriptional states. State 1 mainly comprised clusters 0, 1, 3, and 5; State 2 predominantly consisted of cluster 4; States 3 and 4 were primarily composed of cluster 2; and State 5 mainly included clusters 0, 1, and 5 (Fig. 5B). Based on biological relevance and gene expression characteristics, recMac/Mo-Mac (cluster 4) was annotated as the root state for pseudotime ordering [19, 20]. Accordingly, State 2, which predominantly comprised cluster 4 cells, was designated as the putative early transcriptional state in the inferred trajectory (Fig. 5C).
Fig. 5.
Pseudotime analysis identifies divergent fate programs in
senescent macrophages. (A–D) Cell ordering along the differentiation trajectory
displayed by clusters (A), branch states (B), pseudotime states (C), and
experimental groups (D). (E) Trajectory tree structure illustrating the
distribution and relative abundance of macrophage clusters across each branch
among the AirD7, O2D7, and SD7 groups. S denotes State. (F) Heatmap of all
significantly altered genes identified by branched expression analysis modeling
(BEAM) in Monocle at branch point 1. C1–C3 are self-defined gene modules, where
“C” denotes Cluster. Specifically, C1 represents a group of genes that are
gradually upregulated during differentiation from branch point 1 toward State 3;
C2 represents a group of genes that are gradually upregulated during
differentiation from branch point 1 toward State 4; and C3 represents genes
expressed in the initial cells prior to differentiation toward States 3 and 4.
(G) Bar plot of curated significantly enriched pathways (adjusted p
Cells from the AirD7 and O2D7 groups were primarily distributed toward later pseudotime positions, whereas SD7 cells progressing along branch 2 were enriched at early or intermediate pseudotime stages (Fig. 5D). Fig. 5E depicts the branched trajectory, illustrating the distribution of each cluster across distinct States. The cluster 2 (IMac) cells from the AirD7 and O2D7 groups were predominantly distributed in States 3 and 4, whereas cluster 2 cells from the SD7 group remained in State 4 only along branch 1. The right side of branch 2 corresponds to State 5, which was largely occupied by cells from the SD7 group. State 5 was predominantly composed of clusters 0 and 1 (alvMac) and cluster 6 (ncIMac) in the SD7 group, whereas State 1 was primarily occupied by clusters 0, 1, 3, 5, and 6 in the AirD7 and O2D7 groups. In addition, cluster 5 (pMac) in the SD7 group was mainly distributed at early or intermediate stages of differentiation (i.e., State 2). Together, these distinct cellular distributions indicate divergent fate-associated transcriptional programs in senescent macrophages.
No significant differences in differentiation trajectories along branch 1 were
observed between the O2D7 and AirD7 groups (Fig. 5D,E). Therefore, we focused on
characterizing differentiation-associated and functional disparities in State 4
(IMac) cells in the SD7 group. To identify genes associated with fate
bifurcation, BEAM was applied at branch point 1, revealing genes whose expression
dynamics were significantly associated with branch-dependent fate decisions of
cluster 2 cells. The C2 gene module (Table 8) was progressively upregulated
during differentiation from branch point 1 toward State 4 (Fig. 5F), reflecting
gene activation during the transition from cluster 4 (recMac/Mo-Mac) to cluster 2
(IMac) in the SD7 group. In contrast, the C2 module was downregulated during
differentiation from cluster 4 to cluster 2 in the AirD7 and O2D7 groups,
corresponding to the trajectory from branch point 1 toward State 3. Accordingly,
genes in the C2 module were imported into the DAVID database for functional
enrichment analysis. Representative significantly enriched pathways associated
with differentiation toward State 4 were visualized in a bar plot (Fig. 5G). This
includes inflammatory and immune-related pathways such as CCR chemokine receptor
binding, chemokine-mediated signaling, TNF, NF-
| C1 (53 genes) | C2 (72 genes) | C3 (80 genes) |
| Top2a | Got1 | Gm32796 |
| H1f5 | Id2 | Nlrc3 |
| S100a8 | Ifi207 | S100a11 |
| Gda | Hspa5 | Tmsb10 |
| Rpl41 | Zfand5 | Lsp1 |
| Rpl36a | Irf1 | Mgst1 |
| Alox5ap | Rasgef1b | Chil3 |
| Rassf3 | Mdfic | Atp6v0d2 |
| Smpdl3a | Ccnl1 | Anxa2 |
| Prdx5 | Ctsz | Ccl6 |
| S100a6 | Ctsl | Gdf15 |
| Emb | Klf6 | Gadd45g |
| Sparc | Clec4e | Prdx1 |
| Ccr2 | Rgs1 | Slc7a11 |
| S100a4 | Map2k3 | Mt2 |
| Cldn18 | Cxcr4 | Bhlhe41 |
| Fn1 | Impact | Mt1 |
| Napsa | Nlrp3 | Creg1 |
| Gm9733 | Krt7 | Marco |
| Hbb-bs | Acp5 | Cd36 |
| Hba-a1 | Gas2l3 | Mapk6 |
| Hba-a2 | Lilrb4a | Ralgds |
| Eln | Por | Mfsd12 |
| Hbb-bt | Cxcl2 | Plek |
| Rps27rt | Cd63 | Atp6v1g1 |
| Rpl27a | Ubb | Lmna |
| Ifitm3 | Slc3a2 | Gpr137b |
| Ifi27l2a | H3f3b | Spp1 |
| Cbr2 | Atp6v0c-ps2 | Tnfaip2 |
| Ednrb | Pnrc1 | Lipa |
| Rps15a-ps6 | Nfe2l2 | Dst |
| Anp32a | Atf3 | Ctsd |
| Ccnd3 | Nfkbia | Plin2 |
| Rab27a | Slc38a2 | Sgk1 |
| Timm10b | Tiparp | Nceh1 |
| Coro1a | Basp1 | Il1rn |
| Samhd1 | Retnla | Atp6v1b2 |
| Rpl37rt | Pdgfb | Ndnf |
| Sftpc | Plau | Bc1 |
| Lyz1 | Cxcl10 | Fabp5 |
| Emilin2 | Ccl7 | Soat1 |
| Slc34a2 | Arl4c | Kcnq1ot1 |
| F5 | Zfp36 | Fth1 |
| Alas2 | Junb | Lgals3 |
| Scgb1a1 | Jun | Rab8b |
| Sftpa1 | Ccrl2 | Mmp12 |
| Plac8 | Vegfa | Tlr2 |
| Wfdc2 | Cxcl1 | Gpr137b-ps |
| Ltb4r1 | Ier3 | Ftl1 |
| Gpr35 | Cd14 | Esd |
| Spli | Ctsb | Lilr4b |
| Clic5 | Plk2 | Fnip2 |
| Col4a4 | Fam20c | Csf2rb2 |
| Fos | Cstb | |
| Dusp1 | Gna13 | |
| Cd74 | Mir22hg | |
| Apoe | Sqstm1 | |
| Ccl3 | Rn7sk | |
| Ninj1 | Srxn1 | |
| Ccl4 | Hmox1 | |
| Ccl2 | Txnrd1 | |
| Egr1 | Cebpa | |
| Prg4 | Naa50 | |
| Mfap4 | Malat1 | |
| Col1a1 | Neat1 | |
| Mrc1 | Atp6v1a | |
| Rhob | Eif1a | |
| Abca1 | Ubc | |
| Cd83 | Mdm2 | |
| Runx1 | mt-Rnr2 | |
| Xist | Dtnbp1 | |
| Cebpb | Gclc | |
| Skil | ||
| Ifrd1 | ||
| Ankrd12 | ||
| Atf4 | ||
| Eea1 | ||
| Bcl2a1b | ||
| Erdr1-1 | ||
| Spag9 |
To identify defining features of each senescent macrophage subset, we used cosg() [12] to extract the top upregulated genes (Table 9). The predominant functional categories for each cluster were as follows: Cluster 0—innate immunity, inflammation, lipid metabolism, pentose phosphate pathway; Cluster 1—inflammatory and DNA repair programs; Cluster 2—lipid-associated macrophage markers; Cluster 3—downregulated immune activity and thermogenic genes; Cluster 4—migration and recruitment signatures; Cluster 5—cell-cycle regulation; Cluster 6—lysosomal pathways (Fig. 6A,B). Clusters 0, 1, and 3 were expanded in SD7 relative to AirD7 and O2D7 (Fig. 6C), indicating that senescent macrophages are enriched for inflammatory, metabolic, and innate immune programs.
Fig. 6.
Characterization of macrophage subclusters. (A) Dot plot displays the top ten genes identified in each subcluster using the Cell-type-specific One-vs-all Statistical Gene identification (COSG) algorithm. The size of the dot represents the proportion of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. (B) Biological processes associated with each subcluster’s marker genes. (C) Radar plot depicts the proportion of each macrophage subcluster across the three groups.
| 0 | 1 | 2 | 3 | 4 | 5 | 6 |
| Cdc42ep3 | Mcm2 | C1qc | Gm36027 | Adamdec1 | Ccnb2 | Cracr2a |
| Il18 | Car4 | C1qa | Megf11 | S100a4 | Cdca3 | Atp6v1e1 |
| Acot1 | Cdc42ep2 | C1qb | Ucp1 | Gpr141 | Hmmr | Cox6a2 |
| Lima1 | Dut | C3ar1 | Zmat3 | Gm9733 | Cenpm | Stra6l |
| Rpia | Per2 | Tmem176b | Pcyox1l | Ccr2 | Birc5 | 1700003F12Rik |
| Krt19 | Bok | Fcrls | Gm15738 | Cd300lg | Ube2c | Fam181b |
| Nabp1 | C1ra | Ms4a7 | Vopp1 | Napsa | Cenpe | Clec1b |
| Cnr2 | Dhcr24 | Tmem176a | Ppp1r16a | Ece1 | Cdc20 | Gpnmb |
| Ccdc125 | Abhd17c | Igfbp4 | Gm42027 | Plac8 | Cdkn3 | Gm36598 |
| Pag1 | Pole | Apoe | Nlrc3 | Adgre4 | Lockd | Gm34223 |
| Ipmk | Krt79 | Gas7 | Mamdc2 | Ldhb | Aspm | Anpep |
| Ear1 | Mcm5 | Pdlim4 | Lat | Emb | Cenpf | Cfb |
| Gstm1 | Mcm6 | Ckb | Nt5e | S100a6 | Pimreg | Gm14321 |
| Plcb1 | Hsdl2 | Marcksl1 | Mmp12 | Pilrb2 | Cep55 | Igf2r |
| Pla2g4a | Topbp1 | Sdc4 | Mmp19 | Palm | Racgap1 | 4632404H12Rik |
| Rassf5 | Serpinb1a | Cd86 | Gm34945 | Krt80 | Kif4 | Ccdc66 |
| Mpc2 | Ndufs5 | Stab1 | Tctn3 | Ltb4r1 | Kif15 | Ryr1 |
| Pnpla8 | Dtymk | Cfh | Slc6a4 | Itga4 | Kif20a | Ercc2 |
| Me2 | Gmpr | Tmem37 | Sfxn3 | Sorl1 | Bub1 | Ptpn21 |
| Sh2d1b1 | Mcm4 | Ifitm2 | Mertk | Plcl1 | Kif20b | Vwf |
| Hsd17b4 | Eno1b | Gas6 | Selplg | Mcub | Knstrn | Angptl3 |
| Ear2 | Marco | Marcks | Cd274 | Hp | Foxm1 | N6amt1 |
| Gm31734 | Tipin | Maf | Ccpg1 | Treml4 | Dlgap5 | Ass1 |
| Zfyve26 | Chaf1a | Ninj1 | Ermp1 | Nr4a1 | Tpx2 | Homez |
| Dgat2 | Gk | Pla2g7 | Mcam | Gpr132 | Knl1 | Zfp953 |
| Prkar2b | Flrt3 | Mef2c | Pip5k1c | Hpgd | Sgo2a | Gm40785 |
| Pygl | Fdps | Abca9 | Pik3r6 | Gm32089 | Kif2c | Gm20658 |
| Rab29 | Phgdh | Lacc1 | Itgax | Atp1a3 | Ankle1 | Igf2bp2 |
| Card11 | Hmgn5 | Slc11a1 | Cdh1 | Pilrb1 | Nuf2 | Lrrc42 |
| Abcg1 | Lrp8 | Gpr65 | Gm20219 | Dgkg | Ccnb1 | Gng11 |
| Atxn1 | Ch25h | Aoah | St3gal2 | Adssl1 | Prc1 | Gm14057 |
| Fam192a | Snx7 | Lpcat2 | Miip | Htra3 | Ccna2 | Zranb3 |
| Arfip1 | Rbm14 | Slc9a9 | P2ry14 | Adgre5 | Pclaf | Epas1 |
| Nucb2 | Mcm7 | Itga9 | Klf16 | Gm14548 | Plk1 | Ift43 |
| Spns1 | Fosl1 | Smagp | Lif | Axdnd1 | Mki67 | Ear6 |
| Atp6v0d2 | LOC115490125 | Fyb | E030024N20Rik | Skint3 | Kif23 | Ccbe1 |
| Serpinb1a | Aasdhppt | Itsn1 | Mgmt | Gm2a | Iqgap3 | Ptgir |
| Ndufaf5 | Vars2 | Ms4a6b | Cnot6l | Tatdn3 | Mxd3 | Dcun1d3 |
| Glrx2 | Lig1 | S1pr1 | Pros1 | Cnn2 | Cit | Zscan12 |
| Tnfaip2 | Cdca7 | Ccl2 | Pus10 | Cd244a | Ska1 | Nme7 |
| Abcd2 | Lig3 | Cx3cr1 | Coro6 | Atp10d | Nusap1 | AU022252 |
| Mrpl1 | Spp1 | Serpinb8 | Colec12 | Kcnn4 | Spc25 | Slc2a1 |
| C530008M17Rik | Uhrf1 | Hpgds | L1cam | Gm20559 | Shcbp1 | LOC115488151 |
| Myo6 | Ccnd2 | Mafb | Siglecf | Lilra6 | Cep72 | Cd200 |
| Fam129a | Mcm3 | Blnk | Pbxip1 | Itgb7 | Top2a | Rbks |
| Plscr1 | Tma16 | Ctla2b | Agap1 | Stx2 | Cdca8 | Mllt3 |
| Plin2 | Il1rn | Pmp22 | Gm38927 | Arhgap15 | Tacc3 | 2810454H06Rik |
| Cttnbp2nl | Vaultrc5 | Zfp36l1 | Ppt1 | Gpr35 | Zwilch | Gm29243 |
| Sort1 | Krt19 | Man1a | AY036118 | LOC115489965 | Ncapd2 | Ric8b |
| Nlrp1b | Plpp1 | Igf1 | Mctp1 | Cd52 | Ect2 | Il7r |
Because clusters 0 and 2 expressed metabolic signatures, we evaluated metabolic
gene expression across groups. Clusters 0 and 1 expressed high levels of
metabolic genes, whereas cluster 2 showed comparatively lower expression (Fig. 7A). Relative to AirD7 and O2D7, SD7 macrophages displayed higher glycolysis
genes (Slc2a1, Pkm, Pfkfb3, Ldha,
Hk2, Gapdh), higher pentose phosphate pathway genes
(Tkt, Taldo1, Pgd, G6pdx), and lower
Fig. 7.
Metabolic gene expression and pathway enrichment in macrophage
subclusters. (A,B) Dot plots show metabolic gene expression in macrophage
subclusters (A) and across AirD7, O2D7, and SD7 groups (B). The size of the dot
represents the percentage of cells within a cluster expressing the indicated
gene, while the intensity of expression is indicated by the color legend. (C)
Metabolic pathway enrichment was assessed using the compare_pathways() function
in SCPA, with Wilcoxon tests for significance. ****p
Because clusters 0, 1, and 3 constituted 62.8% of SD7 macrophages, we assessed
metabolic changes specifically within these clusters. In all three clusters,
glycolysis and glutamine metabolism were increased, while
Fig. 8.
Metabolic profiles in alveolar macrophage subcluster 0. (A) Dot
plot shows metabolic gene expression in subcluster 0 across AirD7, O2D7, and SD7
groups. The size of the dot represents the percentage of cells within a cluster
expressing the indicated gene, while the intensity of expression is indicated by
the color legend. (B) Pathway enrichment was evaluated using compare_pathways()
in SCPA; significance was assessed by Wilcoxon test. ***p
Fig. 9.
Metabolic profiles in alveolar macrophage subcluster 1. (A) Dot
plot displays metabolic gene expression in subcluster 1 across AirD7, O2D7, and
SD7 groups. The size of the dot represents the percentage of cells within a
cluster expressing the indicated gene, while the intensity of expression is
indicated by the color legend. (B) Pathway enrichment analysis was performed
using SCPA; statistical significance is indicated as *p
Fig. 10.
Metabolic profiles in alveolar macrophage subcluster 3. (A)
Dot plot shows metabolic gene expression in subcluster 3 among the three groups.
The size of the dot represents the percentage of cells within a cluster
expressing the indicated gene, while the intensity of expression is indicated by
the color legend. (B) Pathway enrichment in subcluster 3 assessed with SCPA.
Wilcoxon test was used to evaluate statistical significance among these groups.
*p
Fig. 11.
Mitochondrial electron transport chain genes in alveolar macrophages. Dot plots show expression of mitochondrial electron transport chain genes in macrophage subclusters 1, 2, and 3 across AirD7, O2D7, and SD7 groups. Dot size represents the proportion of cells expressing each gene, and color intensity indicates expression level.
Using SCPA to compare GO biological processes across groups, we identified pathway alterations characteristic of senescent macrophages. Volcano plots show broad upregulation and downregulation of signal pathways in SD7 relative to AirD7 and O2D7 (Fig. 12A; Tables 10,11,12,13). Upregulated pathways in SD7 group included metal metabolism and homeostasis, amino acid metabolism, interleukin signals, immune effector process, robo receptor signaling, apoptotic signal pathway, heme oxygenase 1 regulation, and RNA process and translation compared to AirD7 (Table 10) and O2D7 (Table 11). Transferrin receptor is a membrane protein which binds to transferrin and mediates cellular iron uptake. This protein is also regulated by intracellular iron levels. Transferrin receptor expression was increased in lamin b1-negative macrophages after neonatal hyperoxia (Fig. 12B), supporting enhanced iron uptake and metabolism in senescent cells.
Fig. 12.
Pathway enrichment in macrophages. Pathway analysis was
performed using compare_pathways() in SCPA. (A) Volcano plots show up- and
down-regulated pathways in SD7 vs. AirD7 (top) and O2D7 (bottom). (B) Dual
immunofluorescence of transferrin receptor (TR) and lamin b1 in pnd7 lungs; and its intensity was compared between air and hyperoxia groups.
White arrows indicate representative lamin b1+/TR+ macrophages in lung sections.
Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal.
Scale bar: 50 µm for the main panel, and 10 µm for the inset. N = 3. (C) Violin plots show differences in p38
MAPK, ATM, mTOR (increased) and JAK/STAT (decreased) pathways in SD7 vs. AirD7
and O2D7; SCPA used for statistics. *p
| Pathway | pval | adjpval | qval | FC |
| REACTOME_Signaling by robo receptors | 5.24 |
2.79 |
8.58 | 1731.38 |
| REACTOME_Translation | 1.91 |
1.02 |
8.83 | 1713.45 |
| REACTOME_Neutrophil degranulation | 4.35 |
2.31 |
9.47 | 1689.21 |
| REACTOME_Regulation of expression of slits and robos | 4.05 |
2.16 |
8.41 | 1675.73 |
| REACTOME_Metabolism of amino acids and derivatives | 1.91 |
1.02 |
8.83 | 1672.43 |
| REACTOME_Cellular response to starvation | 3.28 |
1.74 |
8.70 | 1649.93 |
| REACTOME_Eukaryotic translation initiation | 1.07 |
5.71 |
8.32 | 1586.57 |
| REACTOME_Influenza infection | 1.79 |
9.54 |
8.66 | 1578.42 |
| REACTOME_rRNA processing | 4.05 |
2.16 |
8.41 | 1571.55 |
| REACTOME_Response of Eif2ak4 Gcn2 to amino acid deficiency | 9.74 |
5.18 |
8.62 | 1570.08 |
| REACTOME_Srp dependent cotranslational protein targeting to membrane | 4.05 |
2.16 |
8.41 | 1550.43 |
| REACTOME_Nonsense mediated decay nmd | 4.05 |
2.16 |
8.41 | 1548.40 |
| GOBP_Cytoplasmic translation | 1.48 |
7.87 |
8.49 | 1547.07 |
| REACTOME_Eukaryotic translation elongation | 1.48 |
7.87 |
8.49 | 1541.40 |
| REACTOME_Selenoamino acid metabolism | 5.24 |
2.79 |
8.58 | 1538.65 |
| KEGG_Ribosome | 4.05 |
2.16 |
8.41 | 1506.81 |
| GOBP_Maintenance of location | 2.45 |
1.31 |
9.21 | 1285.58 |
| GOBP_Maintenance of location in cell | 2.45 |
1.31 |
9.21 | 1200.99 |
| GOBP_Transition metal ion homeostasis | 2.45 |
1.31 |
9.21 | 1174.83 |
| GOBP_Cellular transition metal ion homeostasis | 2.45 |
1.31 |
9.21 | 1152.31 |
| REACTOME_Iron uptake and transport | 2.75 |
1.46 |
9.43 | 1034.45 |
| GOBP_Regulation of binding | 1.07 |
5.70 |
8.79 | 905.97 |
| GOBP_Iron ion homeostasis | 4.04 |
2.15 |
9.26 | 904.17 |
| GOBP_Cellular iron ion homeostasis | 2.75 |
1.46 |
9.43 | 883.85 |
| REACTOME_Trans golgi network vesicle budding | 5.23 |
2.78 |
9.09 | 806.38 |
| REACTOME_Golgi associated vesicle biogenesis | 5.23 |
2.78 |
9.09 | 779.28 |
| GOBP_Transition metal ion transport | 5.95 |
3.16 |
8.92 | 773.62 |
| GOBP_Regulation of protein containing complex assembly | 3.39 |
1.80 |
8.87 | 759.23 |
| GOBP_Iron ion transport | 1.91 |
1.02 |
8.83 | 759.16 |
| KEGG_Porphyrin and chlorophyll metabolism | 4.04 |
2.15 |
9.26 | 758.28 |
| REACTOME_Signaling by interleukins | 2.52 |
1.34 |
9.64 | 758.11 |
| GOBP_Ribonucleoprotein complex biogenesis | 3.85 |
2.05 |
7.98 | 740.61 |
| REACTOME_Scavenging by class a receptor | 1.38 |
7.34 |
8.19 | 731.72 |
| GOBP_Positive regulation of locomotion | 2.75 |
1.46 |
9.43 | 731.33 |
| GOBP_Regulation of transmembrane transport | 1.90 |
1.01 |
7.81 | 721.68 |
| REACTOME_Activation of the mRNA upon binding of the cap binding complex and Eifs and subsequent binding to 43s | 8.69 |
4.62 |
7.90 | 713.49 |
| GOBP_Response to wounding | 6.61 |
3.51 |
9.30 | 700.62 |
| REACTOME_Diseases of signal transduction by growth factor receptors and second messengers | 3.08 |
1.63 |
9.04 | 694.08 |
| KEGG_Regulation of actin cytoskeleton | 1.64 |
8.72 |
7.55 | 684.21 |
| GOBP_Negative regulation of binding | 3.28 |
1.74 |
8.70 | 673.40 |
| PID_Myc repress pathway | 1.07 |
5.70 |
8.79 | 654.06 |
| GOBP_Fibroblast proliferation | 3.39 |
1.80 |
8.87 | 647.74 |
| GOBP_Cell chemotaxis | 3.28 |
1.74 |
8.70 | 643.66 |
| GOBP_Negative regulation of fibroblast proliferation | 4.05 |
2.16 |
8.41 | 642.44 |
| REACTOME_Platelet activation signaling and aggregation | 1.48 |
7.87 |
8.49 | 637.33 |
| GOBP_Wound healing | 1.72 |
9.16 |
9.38 | 635.72 |
| GOBP_Regulation of DNA binding transcription factor activity | 8.83 |
4.69 |
9.13 | 633.86 |
| REACTOME_Binding and uptake of ligands by scavenger receptors | 1.04 |
5.51 |
8.96 | 632.66 |
| REACTOME_Signaling by receptor tyrosine kinases | 3.08 |
1.63 |
9.04 | 630.20 |
| GOBP_Ribosome biogenesis | 1.90 |
1.01 |
7.81 | 629.82 |
| Pathway | pval | adjpval | qval | FC |
| GOBP_Cellular transition metal ion homeostasis | 1.86 |
9.90 |
5.48 | 1001.11 |
| GOBP_Transition metal ion homeostasis | 1.86 |
9.90 |
5.48 | 998.49 |
| REACTOME_Iron uptake and transport | 4.52 |
2.41 |
5.26 | 849.00 |
| GOBP_Cellular iron ion homeostasis | 6.21 |
3.31 |
5.70 | 751.98 |
| GOBP_Iron ion homeostasis | 1.86 |
9.90 |
5.48 | 749.76 |
| REACTOME_Neutrophil degranulation | 1.86 |
9.90 |
5.48 | 724.43 |
| KEGG_Porphyrin and chlorophyll metabolism | 4.52 |
2.41 |
5.26 | 665.94 |
| GOBP_Maintenance of location in cell | 1.44 |
7.66 |
4.81 | 644.84 |
| GOBP_Transition metal ion transport | 1.73 |
9.25 |
4.13 | 632.69 |
| GOBP_Iron ion transport | 1.73 |
9.25 |
4.13 | 631.68 |
| REACTOME_Scavenging by class A receptors | 2.00 |
1.07 |
4.36 | 627.95 |
| REACTOME_Golgi associated vesicle biogenesis | 2.00 |
1.07 |
4.36 | 618.57 |
| REACTOME_Trans golgi network vesicle budding | 1.88 |
1.00 |
4.58 | 618.26 |
| GOBP_Maintenance of location | 1.86 |
9.90 |
5.48 | 611.57 |
| PID_MYC repress pathway | 1.73 |
9.25 |
4.13 | 549.94 |
| GOBP_Negative regulation of fibroblast proliferation | 1.73 |
9.25 |
4.13 | 547.25 |
| GOBP_Fibroblast proliferation | 7.02 |
3.74 |
3.66 | 545.84 |
| REACTOME_Regulation of expression of slits and robos | 4.52 |
2.41 |
5.26 | 539.46 |
| REACTOME_Signaling by robo receptors | 8.94 |
4.76 |
5.03 | 535.06 |
| REACTOME_Cellular response to starvation | 1.88 |
1.00 |
4.58 | 509.59 |
| REACTOME_Metabolism of amino acids and derivatives | 1.73 |
9.25 |
4.13 | 503.75 |
| REACTOME_Response of Eif2ak4 Gcn2 to amino acid deficiency | 1.44 |
7.66 |
4.81 | 483.29 |
| REACTOME_Selenoamino acid metabolism | 1.73 |
9.25 |
4.13 | 471.87 |
| REACTOME_Eukaryotic translation initiation | 1.22 |
6.52 |
3.90 | 471.69 |
| REACTOME_SRP dependent cotranslational protein targeting to membrane | 1.22 |
6.52 |
3.90 | 470.94 |
| REACTOME_Translation | 2.00 |
1.07 |
4.36 | 468.91 |
| REACTOME_rRNA processing | 1.73 |
9.25 |
4.13 | 465.72 |
| REACTOME_Nonsense mediated decay NMD | 1.73 |
9.25 |
4.13 | 465.16 |
| REACTOME_Binding and uptake of ligands by scavenger receptors | 1.88 |
1.00 |
4.58 | 464.40 |
| KEGG_Ribosome | 1.73 |
9.25 |
4.13 | 463.05 |
| REACTOME_Influenza infection | 2.00 |
1.07 |
4.36 | 457.23 |
| GOBP_Cytoplasmic translation | 2.00 |
1.07 |
4.36 | 451.70 |
| REACTOME_Eukaryotic translation elongation | 1.22 |
6.52 |
3.90 | 446.34 |
| GOBP_Response to cadmium ion | 1.69 |
8.99 |
5.92 | 344.59 |
| GOBP_Cellular response to cadmium ion | 1.69 |
8.99 |
5.92 | 340.25 |
| GOBP_Cellular response to inorganic substance | 6.21 |
3.31 |
5.70 | 322.96 |
| GOBP_Response to metal ion | 1.69 |
8.99 |
5.92 | 279.12 |
| REACTOME_Signaling by interleukins | 6.21 |
3.31 |
5.70 | 258.01 |
| GOBP_Negative regulation of growth | 4.52 |
2.41 |
5.26 | 254.10 |
| GOBP_Response to copper ion | 4.52 |
2.41 |
5.26 | 252.12 |
| GOBP_Cellular response to copper ion | 1.88 |
1.00 |
4.58 | 251.86 |
| GOBP_Response to zinc ion | 1.88 |
1.00 |
4.58 | 250.47 |
| GOBP_Zinc ion homeostasis | 1.22 |
6.52 |
3.90 | 248.70 |
| GOBP_Regulation of apoptotic signaling pathway | 1.69 |
8.99 |
5.92 | 238.68 |
| REACTOME_Regulation of hmox1 expression and activity | 1.69 |
8.99 |
5.92 | 233.38 |
| GOBP_Divalent inorganic cation homeostasis | 4.52 |
2.41 |
5.26 | 219.77 |
| GOBP_Cellular response to chemical stress | 1.69 |
8.99 |
5.92 | 216.66 |
| REACTOME_Protein localization | 3.73 |
1.99 |
6.14 | 210.47 |
| GOBP_Response to toxic substance | 1.86 |
9.90 |
5.48 | 205.29 |
| GOBP_Immune effector process | 3.73 |
1.99 |
6.14 | 204.38 |
| Pathway | pval | adjpval | qval | FC |
| GOBP_Synaptic membrane adhesion | 1.59 |
0.000843863 | 1.75 | –5.02 |
| GOBP_Chondroitin sulfate proteoglycan metabolic process | 2.47 |
1.31 |
2.81 | –5.09 |
| GOBP_Positive regulation of Rho protein signal transduction | 5.47 |
2.91 |
5.62 | –5.12 |
| GOBP_Regulation of morphogenesis of an epithelium | 6.62 |
3.52 |
6.44 | –5.12 |
| GOBP_Ventricular septum morphogenesis | 1.57 |
8.37 |
6.01 | –5.22 |
| GOBP_Cardiac atrium morphogenesis | 1.46 |
7.78 |
3.33 | –5.25 |
| GOBP_Embryonic eye morphogenesis | 7.54 |
4.01 |
4.52 | –5.26 |
| BIOCARTA_AMI pathway | 5.12 |
2.72 |
5.53 | –5.30 |
| GOBP_Peptide cross linking | 4.73 |
2.52 |
6.05 | –5.33 |
| GOBP_Embryonic skeletal system development | 2.50 |
1.33 |
7.34 | –5.41 |
| GOBP_Neuron projection arborization | 6.50 |
3.46 |
3.93 | –5.42 |
| GOBP_Response to ultraviolet b radiation | 7.84 |
4.17 |
3.66 | –5.42 |
| GOBP_Insulin like growth factor receptor signaling pathway | 7.84 |
4.17 |
3.66 | –5.45 |
| GOBP_Axis elongation | 2.44 |
1.30 |
3.14 | –5.55 |
| REACTOME_Runx2 regulates osteoblast differentiation | 1.31 |
6.96 |
4.92 | –5.58 |
| GOBP_Heart valve development | 7.22 |
3.84 |
7.51 | –5.60 |
| GOBP_Regulation of vasculogenesis | 7.10 |
3.77 |
3.38 | –5.75 |
| GOBP_Positive regulation of cartilage development | 5.12 |
2.72 |
5.53 | –5.77 |
| GOBP_Negative regulation of vascular permeability | 1.64 |
8.71 |
3.75 | –5.81 |
| REACTOME_Chondroitin sulfate dermatan sulfate metabolism | 4.73 |
2.52 |
6.05 | –5.82 |
| GOBP_Response to retinoic acid | 1.27 |
6.76 |
7.08 | –5.92 |
| GOBP_Kidney morphogenesis | 2.05 |
1.09 |
7.00 | –5.99 |
| GOBP_Protein heterooligomerization | 3.60 |
1.91 |
3.70 | –6.00 |
| GOBP_Response to hyperoxia | 5.67 |
3.01 |
5.70 | –6.01 |
| GOBP_Cardiac chamber morphogenesis | 8.69 |
4.62 |
7.90 | –6.19 |
| GOBP_Tooth mineralization | 5.12 |
2.72 |
5.53 | –6.36 |
| PID_Lymph angiogenesis pathway | 5.19 |
2.76 |
5.96 | –6.56 |
| GOBP_Cell aggregation | 9.98 |
0.005303593 | 1.51 | –6.59 |
| GOBP_Neuromuscular junction development | 7.09 |
3.77 |
6.74 | –6.61 |
| REACTOME_Hs gag biosynthesis | 7.10 |
3.77 |
3.38 | –6.75 |
| BIOCARTA_Intrinsic pathway | 1.64 |
8.71 |
3.75 | –7.38 |
| REACTOME_Integrin cell surface interactions | 3.38 |
1.80 |
8.11 | –7.39 |
| GOBP_Outflow tract septum morphogenesis | 2.87 |
1.53 |
4.34 | –7.48 |
| GOBP_Appendage morphogenesis | 1.27 |
6.76 |
7.08 | –7.51 |
| GOBP_Retina vasculature development in camera type eye | 3.32 |
1.76 |
3.84 | –7.61 |
| GOBP_Hydrogen peroxide catabolic process | 1.72 |
9.16 |
9.38 | –7.97 |
| GOBP_Smooth muscle tissue development | 1.01 |
5.35 |
6.65 | –8.10 |
| GOBP_Neuron projection extension involved in neuron projection guidance | 5.12 |
2.72 |
5.53 | –8.28 |
| GOBP_Semi lunar valve development | 2.95 |
1.57 |
6.31 | –8.38 |
| GOBP_Mesonephric tubule morphogenesis | 2.37 |
1.26 |
6.40 | –8.39 |
| REACTOME_Heparan sulfate heparin hs gag metabolism | 5.67 |
3.01 |
5.70 | –8.43 |
| GOBP_Glomerular mesangium development | 2.47 |
1.31 |
2.81 | –8.64 |
| GOBP_Mesenchyme morphogenesis | 1.38 |
7.34 |
6.57 | –8.77 |
| GOBP_Morphogenesis of a branching structure | 5.24 |
2.79 |
8.58 | –8.93 |
| GOBP_Cartilage development involved in endochondral bone morphogenesis | 1.01 |
5.35 |
6.65 | –9.23 |
| GOBP_Regulation of neuron migration | 5.67 |
3.01 |
5.70 | –9.49 |
| GOBP_Mesonephros development | 7.22 |
3.84 |
7.51 | –9.81 |
| REACTOME_A tetrasaccharide linker sequence is required for gag synthesis | 4.83 |
2.57 |
3.10 | –10.05 |
| REACTOME_Defective B4galt7 causes eds progeroid type | 8.62 |
4.58 |
2.71 | –10.10 |
| GOBP_Nephron morphogenesis | 4.73 |
2.52 |
6.05 | –10.18 |
| Pathway | pval | adjpval | qval | FC |
| GOBP_Gas transport | 1.69 |
8.99 |
5.92 | –167.68 |
| GOBP_Regulation of supramolecular fiber organization | 7.02 |
3.74 |
3.66 | –134.42 |
| GOBP_Actin filament organization | 7.02 |
3.74 |
3.66 | –133.83 |
| GOBP_Regulation of cytoskeleton organization | 1.22 |
6.52 |
3.90 | –127.75 |
| REACTOME_Rho gtpase cycle | 1.44 |
7.66 |
4.81 | –122.41 |
| REACTOME_L1cam interactions | 1.25 |
6.65 |
3.19 | –114.44 |
| GOBP_Regulation of actin filament-based process | 7.02 |
3.74 |
3.66 | –114.32 |
| GOBP_Synapse organization | 2.00 |
1.07 |
4.36 | –111.60 |
| GOBP_Morphogenesis of an epithelium | 2.00 |
1.07 |
4.36 | –107.78 |
| GOBP_Regulation of actin filament organization | 1.25 |
6.65 |
3.19 | –103.13 |
| GOBP_Cell substrate adhesion | 1.44 |
7.66 |
4.81 | –103.04 |
| REACTOME_Recycling pathway of L1 | 3.86 |
2.06 |
2.95 | –101.44 |
| GOBP_Hydrogen peroxide catabolic process | 1.88 |
1.00 |
4.58 | –100.48 |
| GOBP_Hydrogen peroxide metabolic process | 4.52 |
2.41 |
5.26 | –99.66 |
| KEGG_Regulation of actin cytoskeleton | 9.76 |
5.20 |
2.70 | –98.75 |
| REACTOME_Gap junction trafficking and regulation | 3.28 |
1.75 |
3.43 | –96.25 |
| GOBP_DNA repair | 2.01 |
1.07 |
2.44 | –93.55 |
| GOBP_Platelet activation | 1.22 |
6.52 |
3.90 | –93.25 |
| REACTOME_Rho gtpases activate formins | 1.73 |
9.25 |
4.13 | –92.79 |
| GOBP_Platelet aggregation | 1.22 |
6.52 |
3.90 | –91.35 |
| REACTOME_Parasite infection | 3.38 |
1.80 |
2.18 | –90.76 |
| KEGG_Focal adhesion | 3.28 |
1.75 |
3.43 | –89.77 |
| REACTOME_Sensory perception | 3.86 |
2.06 |
2.95 | –89.46 |
| REACTOME_Translocation of Slc2a4 Glut4 to the plasma membrane | 7.02 |
3.74 |
3.66 | –88.34 |
| GOBP_Homotypic cell cell adhesion | 1.22 |
6.52 |
3.90 | –88.11 |
| REACTOME_Rho gtpases activate wasps and waves | 2.01 |
1.07 |
2.44 | –87.54 |
| REACTOME_Rho gtpase effectors | 1.88 |
1.00 |
4.58 | –87.45 |
| GOBP_Regulation of body fluid levels | 1.22 |
6.52 |
3.90 | –87.43 |
| GOBP_Actin filament bundle organization | 1.44 |
7.66 |
4.81 | –87.37 |
| KEGG_Pathogenic escherichia coli infection | 1.25 |
6.65 |
3.19 | –86.44 |
| REACTOME_Factors involved in megakaryocyte development and platelet production | 1.25 |
6.65 |
3.19 | –86.21 |
| GOBP_Response to calcium ion | 8.94 |
4.76 |
5.03 | –84.99 |
| REACTOME_Fcgamma receptor fcgr dependent phagocytosis | 1.25 |
6.65 |
3.19 | –84.86 |
| KEGG_Leukocyte transendothelial migration | 3.28 |
1.75 |
3.43 | –83.13 |
| KEGG_Adherens junction | 7.02 |
3.74 |
3.66 | –81.80 |
| GOBP_DNA recombination | 5.19 |
0.002767894 | 1.60 | –81.45 |
| GOBP_Postsynapse organization | 3.28 |
1.75 |
3.43 | –81.45 |
| GOBP_Morphogenesis of a polarized epithelium | 1.25 |
6.65 |
3.19 | –81.44 |
| REACTOME_Ephb mediated forward signaling | 3.86 |
2.06 |
2.95 | –81.33 |
| GOBP_Synaptic vesicle recycling | 2.01 |
1.07 |
2.44 | –81.04 |
| GOBP_Hhemostasis | 1.73 |
9.25 |
4.13 | –80.95 |
| GOBP_Presynaptic endocytosis | 9.76 |
5.20 |
2.70 | –80.86 |
| GOBP_Reactive oxygen species metabolic process | 8.94 |
4.76 |
5.03 | –80.06 |
| REACTOME_Rho gtpases activate iqgaps | 2.00 |
1.07 |
4.36 | –79.86 |
| REACTOME_Eph Ephrin signaling | 7.02 |
3.74 |
3.66 | –79.78 |
| REACTOME_Cell extracellular matrix interactions | 2.01 |
1.07 |
2.44 | –79.63 |
| REACTOME_Cell junction organization | 9.76 |
5.20 |
2.70 | –79.15 |
| REACTOME_Sensory processing of sound | 3.86 |
2.06 |
2.95 | –78.91 |
| REACTOME_Eph Ephrin mediated repulsion of cells | 3.86 |
2.06 |
2.95 | –77.65 |
| GOBP_Vesicle mediated transport in synapse | 9.76 |
5.20 |
2.70 | –76.72 |
Upregulated pathways in SD7 group included lung morphogenesis, ROS/H2O2 detoxification, and Rho GTPase signals were downregulated compared with both AirD7 and O2D7 groups (Tables 12,13). Pathways including morphogenesis, development, branching, vasculogenesis, response to retinoic acid, insulin-like growth factor, and Runx2 were downregulated in the SD7 group compared with the AirD7 group (Table 12). Compared to O2D7 group, filament, cytoskeleton and cell junction organization, adhesion, phagocytosis, Eph/ephrin signaling, and DNA repair pathway were also downregulated in SD7 group (Table 13).
In addition, p38 mitogen-activated kinase (p38 MAPK), ataxia-telangiectasia mutated (ATM), and mechanistic target of rapamycin (mTOR) pathways were strongly enriched in SD7, whereas JAK/STAT signaling was reduced (Fig. 12C). Because p38 MAPK, ATM, and mTOR are central regulators of the SASP [21, 22], these findings suggest that senescent macrophages activate pathways that promote SASP production.
PDK phosphorylates the
Fig. 13.
Activating Pdh decreases neonatal hyperoxia-induced macrophage
senescence and lung injury. C57BL/6J mice (
We previously demonstrated that dasatinib plus quercetin decreases early senescence in hyperoxia-exposed neonatal lungs [6]. To test whether this treatment also mitigates persistent injury, mice received the senolytic cocktail quercetin/dasatinib (2.5 and 5 mg/kg, i.p.) on pnd4 and pnd14 after neonatal hyperoxia. The numbers of lamin b1–/CD68+ cells and p21+/CD68+ were increased by hyperoxia at pnd7, and this was decreased by injection of quercetin/dasatinib (5 mg/kg) (Fig. 14A,B). At pnd60, hyperoxia increased Lm and decreased RAC, consistent with impaired alveolarization, but both changes were significantly improved by senolytic treatment in a dose-dependent manner (Fig. 14C). Neonatal hyperoxia-induced vascular simplification, measured by reduced vWF-positive vessels, was also attenuated by the treatment (Fig. 14D). These findings indicate that reducing senescent lung cells ameliorates long-term structural lung injury after neonatal hyperoxia.
Fig. 14.
Senolytic cocktail mitigates hyperoxia-induced macrophage
senescence and persistent lung injury. C57BL/6J mice (
In this study, we analyzed senescent lung cells collected at pnd7 from neonatal mice exposed to hyperoxia and identified macrophages as the predominant senescent population. Seven macrophage clusters were resolved, with clusters 0, 1, and 3 comprising nearly two-thirds of all senescent macrophages. These clusters were enriched for alveolar and M1-like phenotypes, indicating that senescent macrophages are highly heterogeneous and occupy distinct niches in the developing lung. The predominance of M1-associated signatures suggests that senescent proinflammatory macrophages may amplify hyperoxia-induced lung injury through secretion of SASP mediators [17].
Although macrophages represented the majority of senescent cells, we also detected senescent epithelial, endothelial, and mesenchymal cells, consistent with earlier findings in a rat hyperoxia model [7]. In this dataset, 65.9% of senescent cells were macrophages, a lower proportion than our earlier estimate of 92.1% [6]. This discrepancy likely reflects methodological differences. Our previous analysis relied on automated reference mapping [6], whereas the current study applied hierarchical clustering followed by manual curation to refine macrophage subtype assignments [8]. This approach reduces misclassification and yields more stringent identification of macrophage subpopulations.
Resident alveolar macrophages are diminished following neonatal hyperoxia [23]. Our data similarly show reduced numbers and proportions of these cells in the O2D7 group compared with air controls. Because resident alveolar macrophages support vascular development and aid in the retention of endothelial progenitor cells partly through CXCL12 and other trophic factors, their loss may impair reparative processes and contribute to lung injury [23, 24, 25]. Interestingly, the present study reveals that alveolar macrophages form the largest pool of senescent cells following hyperoxia, raising the possibility that their transition into senescence may disrupt normal homeostatic functions and hinder endothelial maintenance.
Although senescence is commonly regarded as a terminal state, senescent cells can reenter the cell cycle when the pathways enforcing arrest are discontinued [26, 27, 28]. Such cells do not revert to their pre-senescent identity but instead adopt a distinct “post-senescent” phenotype [29, 30]. We identified a cluster of macrophages (cluster 5) expressing proliferative markers, including Cenpf, Mki67, Stmn1, Top2a, and Cdk1, suggesting the presence of a subset with proliferative potential. As expected, these potentially proliferative macrophages were less abundant in the SD7 group than in controls. This cluster of cells were mainly distributed at early or intermediate stages of differentiation based on the pseudotime analysis. Whether senescent macrophages can proliferate after hyperoxic injury in vivo remains unclear and warrants investigation using lineage-tracing and histological approaches.
Metabolic reprogramming is a hallmark of senescence, with increased reliance on
glycolysis and the pentose phosphate pathway to support SASP production [31, 32, 33].
Our analysis indicates that senescent macrophages favor these pathways over fatty
acid
Pdh influences both replicative and oncogene-induced senescence [35, 36]. This
is supported by our findings demonstrating reduced macrophage senescence
following Phd activation by DCA injection. DCA upregulates the cellular
NAD+/NADH ratio by increasing NADH oxidation in mitochondrial complex 1
[37]. Notably, the NAD+/NADH ratio and NAD+-dependent SIRT1 levels are
reduced in peripheral blood mononuclear cells of premature infants with BPD
[38, 39, 40]. Thus, DCA may attenuate hyperoxia-induced macrophage senescence by
increasing the NAD+/NADH ratio, enhancing NAD+-dependent SIRT1 activity, or
modulating other signaling pathways, such as AMPK and HIF-1
Upregulation of electron transport chain genes in senescent macrophages may increase mitochondrial ROS production, and enhanced iron uptake through the transferrin receptor may further augment oxidative stress. Combined with the observed decrease in ROS-detoxifying and DNA-repair pathways, these processes could generate a self-reinforcing cycle of oxidative damage that stabilizes the senescent phenotype [6]. Given that iron overload can drive ferroptosis, it is possible that iron accumulation may mark senescent macrophages for elimination [41, 42]. Examining ferroptosis-related pathways in senescent macrophages may clarify whether this mechanism contributes to their regulation following hyperoxia. Further experiments are warranted to determine whether iron chelation inhibits hyperoxia-induced senescence in macrophages, or whether induction of ferroptosis preferentially eliminates this population.
Key signaling pathways known to govern senescence, including p38 MAPK, ATM, and mTOR, were enriched in senescent macrophages, along with pathways involved in RNA processing and translation, consistent with enhanced SASP gene expression and protein synthesis. Further studies are warranted to determine whether the SASP secretome from senescent macrophages impairs alveolar epithelial wound healing and endothelial tube formation in vitro, as well as alveolarization and vascularization in vivo, and whether these effects can be attenuated by pathway-specific inhibitors. Conversely, pathways associated with phagocytosis were downregulated, in agreement with reports that senescent macrophages exhibit diminished engulfment capacity [43, 44, 45]. Such impairments could further compromise lung repair by reducing clearance of debris, apoptotic cells, and pathogens. This needs further investigation.
This study did not evaluate long-term lung mechanics, including lung compliance and airway resistance, in adult mice following neonatal senolytic clearance of macrophages, which is essential to link alveolar simplification with functional morbidity. Sex-specific responses to senolytic treatment were not assessed and may limit generalizability. Validation of senescent alveolar macrophage accumulation and associated metabolic phenotypes in human BPD lung tissue would facilitate translational relevance. Additionally, the quercetin/dasatinib cocktail may exert off-target toxicity toward non-senescent cells [46]. Future studies should prioritize the development of targeted approaches to selectively eliminate senescent macrophages for BPD therapy in an optimal therapeutic window.
Neonatal hyperoxia induces pronounced cellular senescence in the developing lung, with macrophages-particularly alveolar and M1-polarized subsets-constituting the dominant senescent population. These senescent macrophages undergo metabolic reprogramming characterized by increased reliance on glycolysis and the pentose phosphate pathway, accompanied by dysregulation of oxidative stress responses, inflammatory signaling, and tissue repair pathways. Activation of Pdh attenuates hyperoxia-induced macrophage senescence, while selective clearance of this population mitigates the development of chronic lung injury following neonatal hyperoxia. Collectively, these findings identify senescent macrophages as key mediators of persistent lung injury and highlight metabolic and senescence-associated pathways as potential targets for therapeutic intervention of BPD.
The paper is listed as, “Characterization of hyperoxia-induced senescent lung macrophages in neonatal mice” as a preprint on (bioRxiv) at: https://doi.org/10.1101/2025.05.09.652066.
All raw data used and analyzed in this study are available from the corresponding author upon reasonable request. Analysis of the scRNA-seq data used publicly available R packages and custom scripts, which are also available from the corresponding author upon reasonable request.
FL, JW, WL reanalyzed publicly available scRNA-seq datasets. EP and BM performed animal exposure and immunostaining. HY designed the study, conducted experiments, drafted the initial manuscript, and revised the manuscript. PAD assisted with the experimental design and edited the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.
All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee of Brown University (IACUC: 21-08-0003) and Providence VA Medical Center (IACUC: 2024-003). Animal experiments were performed according to the ARRIVE guidelines.
We thank Katy Hegarty and Emerson Kopsack for their technical support. We thank Dr. Xin Li (Dartmouth College) for his discussion on the scRNA-seq analysis of hierarchical clustering of macrophages. The views expressed in this article are those of the authors and do not reflect the position or policy of the Department of Veterans Affairs or the US Federal Government.
This work was supported in part by the NIH grant R01HL166327, an Institutional Development Award (IDeA) from the NIGMS of NIH under grant #P30GM149398 (HY), and the Warren Alpert Foundation of Brown University (PAD).
The authors declare no conflict of interest. Given his role as the Editorial Board member, Hongwei Yao had no involvement in the peer-review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Esteban C. Gabazza.
References
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.














